COVID-19相关ARDS呼吸系统静态顺应性:一项国际多中心研究
本研究为国际多中心观察性队列,纳入372例中重度COVID-19相关ARDS患者,于第1天和第14天测定呼吸系统静态顺应性(Crs)。平均Crs为37.6 ± 13 mL/cmH2O,与其他病因ARDS相似。多因素分析显示,在校正混杂因素后,Crs(OR 1.0,95%CI 0.98-1.02)和Crs/IBW(OR 0.63,95%CI 0.13-3.1)均与第28天无需辅助呼吸的概率无关,而平台压与第28天无需辅助呼吸的概率相关(OR 0.93,95%CI 0.88-0.99)。108例仍在控制性机械通气的患者中,第14天Crs较第1天下降(31.2 ± 14.4 mL/cmH2O vs 37.8 ± 11.4 mL/cmH2O,p < 0.001),该下降与28天结局无关。
要点
- 372例中重度COVID-19相关ARDS患者平均Crs为37.6 ± 13 mL/cmH2O,与其他病因ARDS相似
- 校正混杂后Crs(OR 1.0,95%CI 0.98-1.02)和Crs/IBW(OR 0.63,95%CI 0.13-3.1)与第28天无需辅助呼吸无关
- 平台压与第28天无需辅助呼吸的概率相关(OR 0.93,95%CI 0.88-0.99)
- 108例仍在控制性通气患者第14天Crs较第1天下降(31.2 ± 14.4 vs 37.8 ± 11.4 mL/cmH2O,p < 0.001),与28天结局无关
- 慢性高血压、低PaO2/FiO2、低PEEP、低潮气量与较低的Crs/IBW相关
适用人群与场景
- 国际多中心观察性队列,中重度COVID-19相关ARDS患者372例
- 第14天Crs与第1天比较的亚组为108例仍在控制性机械通气的患者
研究设计与关键结果
- 观察性多中心队列:372例中重度COVID-19相关ARDS患者第1天平均Crs为37.6 ± 13 mL/cmH2O
- 多因素线性回归:慢性高血压、低PaO2/FiO2、低PEEP和低潮气量与较低的Crs/IBW相关
- 校正混杂因素后,Crs与第28天无需辅助呼吸无关(OR 1.0,95%CI 0.98-1.02),Crs/IBW亦无关(OR 0.63,95%CI 0.13-3.1)
- 平台压与第28天无需辅助呼吸相关(OR 0.93,95%CI 0.88-0.99)
- 108例患者第14天Crs较第1天下降(31.2 ± 14.4 mL/cmH2O vs 37.8 ± 11.4 mL/cmH2O,p < 0.001),该下降与第28天结局无关
证据类型、等级与局限
- 证据类型:观察性国际多中心队列研究
- 局限:原文未报告局限性
对床旁实践的改变
- 提示在COVID-19相关ARDS中不宜仅依据Crs判断预后,平台压与第28天无需辅助呼吸相关
- Crs在第1天至第14天可下降,但该下降未与第28天结局相关
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Controversies exist on the nature of COVID-19 related acute respiratory distress syndrome (ARDS) in particular on the static compliance of the respiratory system (Crs). We aimed to analyze the association of Crs with outcome in COVID-19-associated ARDS, to ascertain its determinants and to describe its evolution at day-14.
METHODS: In this observational multicenter cohort of patients with moderate to severe Covid-19 ARDS, Crs was measured at day-1 and day-14. Association between Crs or Crs/ideal body weight (IBW) and breathing without assistance at day-28 was analyzed with multivariable logistic regression. Determinants were ascertained by multivariable linear regression. Day-14 Crs was compared to day-1 Crs with paired t-test in patients still under controlled mechanical ventilation.
RESULTS: The mean Crs in 372 patients was 37.6 ± 13 mL/cmH2O, similar to as in ARDS of other causes. Multivariate linear regression identified chronic hypertension, low PaO2/FiO2 ratio, low PEEP, and low tidal volume as associated with lower Crs/IBW. After adjustment on confounders, nor Crs [OR 1.0 (CI 95% 0.98-1.02)] neither Crs/IBW [OR 0.63 (CI 95% 0.13-3.1)] were associated with the chance of breathing without assistance at day-28 whereas plateau pressure was [OR 0.93 (CI 95% 0.88-0.99)]. In a subset of 108 patients, day-14 Crs decreased compared to day-1 Crs (31.2 ± 14.4 mL/cmH2O vs 37.8 ± 11.4 mL/cmH2O, p < 0.001). The decrease in Crs was not associated with day-28 outcome.
CONCLUSION: In a large multicenter cohort of moderate to severe COVID-19 ARDS, mean Crs was decreased below 40 mL/cmH2O and was not associated with day-28 outcome. Crs decreased between day-1 and day-14 but the decrease was not associated with day-28 outcome.
参考来源
- Vandenbunder B, Ehrmann S, Piagnerelli M, et al. Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study. Crit Care. 2021. PMID: 33557868. doi:10.1186/s13054-020-03433-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。